Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-04-06, Stock:JNJ, The news for the past five days is as follows:
2021-03-29: NEWS1: Top Analyst Reports for Johnson & Johnson, Nike & Morgan Stanley.NEWS2: UPDATE 1-U.S. vaccination campaign gains steam as White House speeds shipments.NEWS3: One dose of Pfizer or Moderna vaccine is 80% effective: CDC.NEWS4: 3 High Ebitda Margin Ratio Stock Picks.NEWS5: J&J's (JNJ) Pharma Unit & COVID-19 Vaccine Key to 2021 Growth.NEWS6: Johnson & Johnson Signs Single-Shot COVID-19 Vaccine Deal With AVAT.NEWS7: Bluebird Shares Jump as FDA Approves Cancer Therapy.NEWS8: White House Contemplates Waiving-Off Patent Protections For COVID-19 Treatments.NEWS9: JNJ Inks COVID-19 Vaccine Supply Pact With African Union.NEWS10: Next Stock Market Crash: 2 Bulletproof Value Stocks to Buy.NEWS11: Exclusive: J&J CEO pay irks investors upset with opioid lawsuits fallout.NEWS12: Moderna Completes Delivery of First 100 Million COVID Shots to U.S..NEWS13: UPDATE 3-J&J, African Union in deal for up to 400 mln COVID-19 shots.NEWS14: Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Task Team for the Company's COVID-19 Vaccine Candidate.NEWS15: Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company's COVID-19 Vaccine Candidate.NEWS16: S.Korea's expert panel says J&J COVID-19 vaccine safe, effective for approval.
2021-03-30: NEWS1: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS2: UPDATE 1-Spain to use AstraZeneca vaccine in 55-65 age group, J&J for older people.NEWS3: Pandemic led to aggressive adoptions of technology in sports: Teamworks CEO.NEWS4: The Rockefeller Foundation is teaming up with COVID-19 testing companies to reopen schools safely.NEWS5: We can vaccinate our way out of this phase of the pandemic: Doctor .NEWS6: Got $3000? Here Are 3 Stocks to Buy and Hold for the Long Term.NEWS7: Why the COVID ‘superhero villain tug-of-war’ will be an eternal battle.NEWS8: The Zacks Analyst Blog Highlights: Johnson & Johnson, NIKE, Morgan Stanley, Deere & Co and ViacomCBS.NEWS9: Is J&J Stock A Buy Now That The FDA Has Authorized Its Covid Vaccine?.
2021-03-31: NEWS1: J&J Covid Vaccine Shipments Halted As Plant Mix-Up Ruins 15 Million Doses.NEWS2: UPDATE 2-J&J finds problem with COVID vaccine batch; NYTimes says 15 mln doses ruined.NEWS3: Here's What You Need to Know About COVID Variants' Impact on Vaccine Efficacy.
2021-04-01: NEWS1: Why Emergent BioSolutions Crashed Today.NEWS2: US STOCKS-S&P 500 rides Microsoft, Amazon to record close above 4,000.NEWS3: 'The important thing is to have as many Americans vaccinated as possible': Doctor.NEWS4: US STOCKS-S&P 500 rides Microsoft, Amazon to record close north of 4,000.NEWS5: Quidel issued first emergency use authorization by FDA for a COVID-19 antigen test.NEWS6: EU Turns To India To Fill AstraZeneca Vaccine Supply Gap: Reuters.NEWS7: How Biden’s ‘momentous’ rescue plan helps older Americans: NCOA President.NEWS8: Layers of mitigation against the virus remains ‘critical’: Doctor.NEWS9: Investors should reject J&J CEO pay package, proxy adviser Glass Lewis says.NEWS10: Dow Jones Rallies, S&P 500 Tops 4,000 As Stock Market Gets Biden Boost.NEWS11: Anytime there’s a bad headline about these vaccines, it’s going to add to vaccine hesitancy: Dr. Amesh Adalja .NEWS12: US STOCKS-S&P 500 hits 4,000 mark on tech strength, reopening optimism.NEWS13: Dow Jones Climbs, S&P 500 Tops 4000 For First Time As Stock Market Rallies.NEWS14: Pfizer and BioNTech say their COVID-19 vaccine is safe and highly effective — including against South Africa variant.NEWS15: US STOCKS-S&P 500 hits 4,000 mark on tech strength, reopening optimism.NEWS16: Pfizer, Biotech vaccine shows strong results after 6 months.NEWS17: SpringWorks Therapeutics Stock Is Trading Higher After Nirogacestat Combo Study Starts Dosing In Multiple Myeloma Patients.NEWS18: Emergent's stock falls 6.8% after error making J&J's COVID-19 vaccine.NEWS19: Emergent BioSolutions Stock Falls After Vaccine Factory Mix-Up.NEWS20: Forget the Vaccine Problems, AstraZeneca Stock Can Still Make You Rich.NEWS21: 3 Dividend Aristocrats to Buy and Hold Forever.NEWS22: US STOCKS-Futures rise as tech stocks gain ahead of weekly jobless claims data.NEWS23: Pfizer Versus Moderna: Which Is Leading U.S. Vaccine Rollout?.NEWS24: Here's How Today's Vaccines Are Holding Up to Strains Right Now.NEWS25: This Company May Be Next to Enter the U.S. Vaccine Market.NEWS26: 15M Doses Of JNJ COVID-19 Vaccine Batch Ruined After Ingredient Issues At Emergent Biosolutions' US Plant: NYT.NEWS27: Emergent, J&J Fall As Production Mix-Up To Cause Vaccine Delays.NEWS28: Johnson & Johnson Slips After Vaccine Batch Hit by Production Mix-Up.NEWS29: J&J sticks to vaccine targets after batch ruined in factory error.
2021-04-05: NEWS1: Johnson & Johnson Given Control of Emergent BioSolutions Factory That Botched Its Coronavirus Vaccine.NEWS2: The IBD/TIPP Poll Gives These 3 Covid Vaccine Stocks Reason To Be Bullish.NEWS3: Travel boom poses threat to COVID-19 recovery: Doctor.NEWS4: UPDATE 1-White House says removal of AstraZeneca vaccine from U.S. plant will not affect dose output.NEWS5: Johnson & Johnson Becomes Third Company To Expand COVID-19 Vaccine Study To Adolescents.NEWS6: White House's removal of AstraZeneca COVID-19 shot production from Emergent plant won't affect its dose output - official.NEWS7: Emergent (EBS) Gets Extra $23M for COVID-19 Vaccine Production.NEWS8: U.S. COVID vaccine program speeds up to about 3 million doses a day in the past week.NEWS9: J&J Will Manufacture Its Own Vaccine at Emergent Facility Where Doses Were Ruined.NEWS10: SpringWorks (SWTX) Begins Dosing in Multiple Myeloma Study.NEWS11: Cidara Therapeutics Stock Rises After Collaboration Agreement Janssen For Influenza Candidates.NEWS12: Is J&J Stock A Buy Now That The FDA Has Authorized Its Covid Vaccine?.NEWS13: Emergent BioSolutions' Plasma-Based Therapy Candidate Flunks COVID-19 Study; HHS Increases Task Order By $23M.NEWS14: J&J (JNJ) Gets Full Charge of Emergent COVID-19 Vaccine Plant.NEWS15: Emergent BioSolutions says on track with COVID vaccines, reaffirms guidance after J&J vaccine snafu.NEWS16: I'm Buying Arcturus Therapeutics Stock and Here's the Reason Why.NEWS17: Vaccine Stocks Checkup: Johnson & Johnson, Pfizer Update.NEWS18: Covid-19 Vaccine Update And Outlook Amid New Variants, Hiccups For Some Vaccine Developers.NEWS19: Emergent gets $23 mln additional order for vaccine production.

Answer: Decrease